📣 VC round data is live. Check it out!
- Public Comps
- Telemedycyna Polska
Telemedycyna Polska Valuation Multiples
Discover revenue and EBITDA valuation multiples for Telemedycyna Polska and similar public comparables like Aino Health, Andiamo, Monsenso, Medondo Holding and more.
Telemedycyna Polska Overview
About Telemedycyna Polska
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
Founded
2005
HQ

Employees
35
Website
Sectors
Financials (FY)
EV
$3M
Valuation Multiples
Start free trialTelemedycyna Polska Financials
Telemedycyna Polska reported last fiscal year revenue of $1M and negative EBITDA of ($319K).
In the same fiscal year, Telemedycyna Polska generated $1M in gross profit, ($319K) in EBITDA losses, and had net loss of ($404K).
Telemedycyna Polska P&L
In the most recent fiscal year, Telemedycyna Polska reported revenue of $1M and EBITDA of ($319K).
Telemedycyna Polska is unprofitable as of last fiscal year, with gross margin of 92%, EBITDA margin of (22%), and net margin of (28%).
Financial data powered by Morningstar, Inc.
Telemedycyna Polska Stock Performance
Telemedycyna Polska has current market cap of $3M, and enterprise value of $3M.
Market Cap Evolution
Telemedycyna Polska's stock price is $0.22.
Telemedycyna Polska share price increased by 8.9% in the last 30 days, and by 37.5% in the last year.
Telemedycyna Polska has an EPS (earnings per share) of $-0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $3M | 8.9% | 8.9% | 57.7% | 37.5% | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTelemedycyna Polska Valuation Multiples
Telemedycyna Polska trades at 2.0x EV/Revenue multiple, and (9.0x) EV/EBITDA.
Telemedycyna Polska Financial Valuation Multiples
As of June 2, 2026, Telemedycyna Polska has market cap of $3M and EV of $3M.
Telemedycyna Polska has a P/E ratio of (7.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Telemedycyna Polska Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Telemedycyna Polska Margins & Growth Rates
In the most recent fiscal year, Telemedycyna Polska reported gross margin of 92%, EBITDA margin of (22%), and net margin of (28%).
Telemedycyna Polska Margins
Telemedycyna Polska Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Telemedycyna Polska Operational KPIs
Telemedycyna Polska's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Telemedycyna Polska Competitors
Telemedycyna Polska competitors include Aino Health, Andiamo, Monsenso, Medondo Holding, 1933 Industries, Alternate Health, Feedback, Brain Scientific, Ludwig Enterprises and Premier Health Of America.
Most Telemedycyna Polska public comparables operate across Health Data & Analytics, Healthcare Software, Telemedicine & Virtual Care, B2B SaaS, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | - | (11.9x) | - | |||
| - | - | - | - | |||
| 2.0x | - | (5.9x) | - | |||
| 3.8x | - | (5.6x) | - | |||
| 1.0x | - | 17.5x | - | |||
| - | - | - | - | |||
| (0.3x) | (0.3x) | 0.1x | 0.1x | |||
| - | - | - | - | |||
This data is available for Pro users. Sign up to see all Telemedycyna Polska competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Telemedycyna Polska
| When was Telemedycyna Polska founded? | Telemedycyna Polska was founded in 2005. |
| Where is Telemedycyna Polska headquartered? | Telemedycyna Polska is headquartered in Poland. |
| How many employees does Telemedycyna Polska have? | As of today, Telemedycyna Polska has over 35 employees. |
| Is Telemedycyna Polska publicly listed? | Yes, Telemedycyna Polska is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Telemedycyna Polska? | Telemedycyna Polska trades under TMP ticker. |
| When did Telemedycyna Polska go public? | Telemedycyna Polska went public in 2010. |
| Who are competitors of Telemedycyna Polska? | Telemedycyna Polska main competitors include Aino Health, Andiamo, Monsenso, Medondo Holding, 1933 Industries, Alternate Health, Feedback, Brain Scientific, Ludwig Enterprises, Premier Health Of America. |
| What is the current market cap of Telemedycyna Polska? | Telemedycyna Polska's current market cap is $3M. |
| What is the current revenue of Telemedycyna Polska? | Telemedycyna Polska's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Telemedycyna Polska? | Current revenue multiple of Telemedycyna Polska is 2.0x. |
| Is Telemedycyna Polska profitable? | No, Telemedycyna Polska is not profitable. |
| How many companies Telemedycyna Polska has acquired to date? | Telemedycyna Polska hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Telemedycyna Polska has invested to date? | Telemedycyna Polska hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Telemedycyna Polska
Lists including Telemedycyna Polska
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.